Auto-generated from public data. Not the firm's stated position.
CAPNOVA appears to focus on early-stage investments across biotech, healthtech, edtech, and SaaS sectors, with a particular emphasis on deep-tech and hardware-enabled solutions. Recent portfolio companies suggest an interest in specialized manufacturing technologies, medical devices, and software tools that address niche technical problems. The firm's check size range of €0.1M, €1.5M and concentration on pre-seed and seed stages indicate a strategy of backing technically differentiated founders in Northern Europe.
Generated 1 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from CAPNOVA's website.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.